Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma (Q40953356)
Jump to navigation
Jump to search
scientific article published on February 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma |
scientific article published on February 1999 |
Statements
1 reference
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma (English)
1 reference
Wang M
1 reference
Wise SC
1 reference
Leff T
1 reference
Su TZ
1 reference
1 February 1999
1 reference
1 reference
48
1 reference
2
1 reference
254-260
1 reference
Identifiers
1 reference
1 reference